Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium

R A Eiferman1, J P Snyder, R E Nordquist

  • 1Research Service, Veterans Administration Medical Center, Louisville, Kentucky, USA. reiferman@cs.com

Insights

Ciprofloxacin eye drops can form precipitates in the cornea after surgery. These precipitates, identified as pure ciprofloxacin, showed antibacterial activity in lab tests.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Materials Science

Background:

  • Corneal transplantation is a surgical procedure to restore vision.
  • Ciprofloxacin ophthalmic drops are commonly used to prevent infection.
  • Epithelial damage can occur during or after corneal surgery.

Observation:

  • Microprecipitates were observed in the corneas of 2 out of 4 patients receiving preoperative ciprofloxacin.
  • A large macroprecipitate formed in a corneal ulcer in another patient.
  • These precipitates were analyzed using electron microscopy and high-pressure liquid chromatography.

Findings:

  • The crystalline precipitates were identified as pure ciprofloxacin.
  • The macroprecipitate exhibited significant antibacterial activity in vitro, demonstrating a large zone of inhibition.
  • The precipitates were confirmed to be bioactive and bioavailable in laboratory settings.

Implications:

  • Ciprofloxacin precipitates may form in damaged corneal tissue.
  • The precipitates retain antibacterial properties, suggesting potential therapeutic roles.
  • Further research is needed to understand the clinical significance and management of these precipitates in ophthalmic surgery.